Deadlock ransomware targeted BioResearch in Poland, impacting the BioResearch Group’s Warsaw clinical research center specializing in early phases (I, FIH, SAD, MAD) and bioequivalence studies, including operations supported by its own clinic and laboratory. The incident affected pharmaceutical and CRO services provided from Warsaw’s facilities. #Poland
Incident Details
- Victim: BioResearch
- Sector: Healthcare
- Country: PL
- Actor: Deadlock
- Source: http://deadblogdbdu5wprek7wa2o4ce7rnt6u6ntqeud3hzjjcveosgpsqqqd.onion/s3.php?d=d2FzYWJpOmRhdGEtYmlvcmVzZWFyY2gucGx8ZXUtY2VudHJhbC0xfFY0MVVLVEM5U1FIOThXMjdCRlk3fFZjTkRmUVloZ2V1cThteXM0SnJKd2kwcmVkQVpuUE1Qb05WRGlZNXY%3D
- Discovered: 2026-07-25T17:55:18.884181+00:00
- Published: 2026-07-25T00:00:00+00:00
Information
- BioResearch Group, a Warsaw-based clinical research center, specializes in early-phase studies, including I, FIH, SAD, MAD, and bioequivalence studies.
- The company provides comprehensive services for the pharmaceutical and CRO sectors through its own clinic and laboratory.
Disclaimer: This post is based on public claims made by the ransomware group "Deadlock". I cannot confirm the accuracy of the information. However, I would be happy to share any official statement from the affected organization to provide clarification.